These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9060563

  • 1. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
    Van Tornout JM, Buckley JD, Quinn JJ, Feusner JH, Krailo MD, King DR, Hammond GD, Ortega JA.
    J Clin Oncol; 1997 Mar; 15(3):1190-7. PubMed ID: 9060563
    [Abstract] [Full Text] [Related]

  • 2. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
    Koh KN, Park M, Kim BE, Bae KW, Kim KM, Im HJ, Seo JJ.
    Pediatr Blood Cancer; 2011 Oct; 57(4):554-60. PubMed ID: 21370433
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pretransplant trends in α-fetoprotein levels as a predictor of recurrence after living donor liver transplantation for unresectable hepatoblastoma: A single-institution experience.
    Isono K, Ohya Y, Lee KJ, Hashimoto S, Kadohisa M, Sakisaka M, Uto K, Hayashida S, Yamamoto H, Yamamoto H, Sugawara Y, Inomata Y.
    Pediatr Transplant; 2018 Aug; 22(5):e13221. PubMed ID: 29761829
    [Abstract] [Full Text] [Related]

  • 5. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, Superina RA.
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [Abstract] [Full Text] [Related]

  • 6. Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.
    Katzenstein HM, Furman WL, Malogolowkin MH, Krailo MD, McCarville MB, Towbin AJ, Tiao GM, Finegold MJ, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Rodriguez-Galindo C, Meyers RL.
    Cancer; 2017 Jun 15; 123(12):2360-2367. PubMed ID: 28211941
    [Abstract] [Full Text] [Related]

  • 7. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.
    Ortega JA, Krailo MD, Haas JE, King DR, Ablin AR, Quinn JJ, Feusner J, Campbell JR, Lloyd DA, Cherlow J.
    J Clin Oncol; 1991 Dec 15; 9(12):2167-76. PubMed ID: 1720452
    [Abstract] [Full Text] [Related]

  • 8. Can we predict the prognosis of resectable hepatoblastoma from serum alpha-fetoprotein response during preoperative chemotherapy?
    Fukuzawa H, Urushihara N, Fukumoto K, Mitsunaga M, Watanabe K, Aoba T, Yamoto S, Miyake H, Hasegawa S.
    Pediatr Surg Int; 2012 Sep 15; 28(9):887-91. PubMed ID: 22948667
    [Abstract] [Full Text] [Related]

  • 9. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89.
    von Schweinitz D, Hecker H, Harms D, Bode U, Weinel P, Bürger D, Erttmann R, Mildenberger H.
    J Pediatr Surg; 1995 Jun 15; 30(6):845-52. PubMed ID: 7545228
    [Abstract] [Full Text] [Related]

  • 10. Effect of postoperative chemotherapy on the serum alpha-fetoprotein level in hepatoblastoma.
    Kubota M, Yagi M, Kanada S, Yamazaki S, Tanaka S, Asami K, Ogawa A, Watanabe A, Iwabuchi H, Kaneko M, Saida Y.
    J Pediatr Surg; 2004 Dec 15; 39(12):1775-8. PubMed ID: 15616926
    [Abstract] [Full Text] [Related]

  • 11. Carboplatin-epirubicin regimen for the treatment of hepatoblastoma.
    Blouin P, Brugières L, Tabone MD, Leverger G, Rubie H, Branchereau S, De Kraker J.
    Pediatr Blood Cancer; 2004 Feb 15; 42(2):149-54. PubMed ID: 14752879
    [Abstract] [Full Text] [Related]

  • 12. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Feb 15; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 13. Features predicting unresectability in hepatoblastoma.
    D'Antiga L, Vallortigara F, Cillo U, Talenti E, Rugge M, Zancan L, Dall'Igna P, De Salvo GL, Perilongo G.
    Cancer; 2007 Sep 01; 110(5):1050-8. PubMed ID: 17661341
    [Abstract] [Full Text] [Related]

  • 14. Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy.
    Nguyen R, McCarville MB, Sykes A, Mao S, Wu J, Langham MR, Furman WL.
    Int J Clin Oncol; 2018 Oct 01; 23(5):900-907. PubMed ID: 29744604
    [Abstract] [Full Text] [Related]

  • 15. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
    von Schweinitz D, Bürger D, Bode U, Weinel P, Erttmann R, Hecker H, Mildenberger H.
    Klin Padiatr; 1994 Oct 01; 206(4):282-8. PubMed ID: 7526028
    [Abstract] [Full Text] [Related]

  • 16. Treatment of alpha-fetoprotein secreting hepatoblastoma by response of serum alpha-fetoprotein levels: a new concept.
    Sayar D, Yaniv I, Goshen Y, Cohen IJ.
    Pediatr Hematol Oncol; 2001 Dec 01; 18(8):509-18. PubMed ID: 11764100
    [Abstract] [Full Text] [Related]

  • 17. Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: stable radiographic disease with decreased AFP.
    Marsh AM, Lo L, Cohen RA, Feusner JH.
    Pediatr Blood Cancer; 2012 Nov 01; 59(5):939-40. PubMed ID: 22492703
    [Abstract] [Full Text] [Related]

  • 18. Serum α-fetoprotein concentration in extremely low-birthweight infants.
    Maruyama K.
    Pediatr Int; 2017 Feb 01; 59(2):159-162. PubMed ID: 27400853
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
    Zsíros J, Brugières L, Brock P, Roebuck D, Maibach R, Child M, Morland B, Casanova M, Pariente D, Paris C, de Camargo B, Ronghe M, Zimmermann A, Plaschkes J, Czauderna P, Perilongo G.
    Eur J Cancer; 2012 Dec 01; 48(18):3456-64. PubMed ID: 22835780
    [Abstract] [Full Text] [Related]

  • 20. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
    Katzenstein HM, London WB, Douglass EC, Reynolds M, Plaschkes J, Finegold MJ, Bowman LC.
    J Clin Oncol; 2002 Aug 15; 20(16):3438-44. PubMed ID: 12177104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.